Pfizer Limited announced its unaudited results for the quarter ended June 30, 2020.
Revenues
Revenue from operations for the quarter ended June 30, 2020 is Rs. 515 crore as compared to Rs. 544 crore in the same period last year.
The current quarter sales have been impacted due to COVID-19. Hospitals and Vaccines business have a higher impact as compared to the established products business. Current quarter results are also impacted by divestment of rights and interests in certain brands in December 2019.
Profits before other income and tax
Profit from operations (before other income and tax) for the quarter ended June 30, 2020 is Rs. 159 crore.
Profit after tax
Net Profit after tax (including other comprehensive income) for the quarter ended June 30, 2020 is Rs. 125 crore as against Rs. 113 crore in the same period last year.
COVID-19
The COVID-19 pandemic and consequent Nationwide lockdown have impacted regular business operations. The Company has monitored the impact of COVID-19 on all aspects of its business. The Management has exercised due care, in concluding on significant accounting judgements and estimates, recoverability of receivables, assessment for impairment of goodwill, intangible assets, inventory based on the information available as on date, while preparing the financial results.
In view of the continued uncertainties and its inability to predict the extend and duration of COVID-19 situation, the Company currently is unable to predict any future impact on its business operations. The Company will continue to ensure supply of essential medicines and take steps to mitigate any risks associated with COVID-19 pandemic.
Shares of PFIZER LTD. was last trading in BSE at Rs.4371 as compared to the previous close of Rs. 4341.95. The total number of shares traded during the day was 6278 in over 1381 trades.
The stock hit an intraday high of Rs. 4444.65 and intraday low of 4346.75. The net turnover during the day was Rs. 27611492.